Clinical Trial Update: Copeptin in the Diagnosis of Post-operative Insipidus Diabetes After Pituitary Surgery [NA]

View source ↗

Summary

The trial evaluated copeptin as a diagnostic biomarker for postoperative diabetes insipidus after pituitary surgery; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Insipidus

Snippet

Sponsor: CHU de Reims | Conditions: Pituitary Surgery | NA | Status: COMPLETED